Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,792 papers from all fields of science
Search
Sign In
Create Free Account
SYTO 9
Known as:
SYTO-9
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Organic Chemicals
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Rapid and quantitative detection of citrus huanglongbing bacterium ‘ Candidatus Liberibacter asiaticus ’ by real-time fl uorescent loop-mediated isothermal ampli fi cation assay in China
Xu-su Wu
,
Chun-yan Meng
,
+4 authors
Jun Peng
2016
Corpus ID: 21989798
Huanglongbing (HLB) is a devastating citrus disease that is associated with bacteria of the species ‘Candidatus Liberibacter…
Expand
2015
2015
Strategies of fluorescence staining for trace total ribonucleic acid analysis by capillary electrophoresis with argon ion laser‐induced fluorescence
Yi-An Chung
,
Yi-Hsin Chen
,
Po-Ling Chang
Electrophoresis
2015
Corpus ID: 25165380
In this work, five fluorescent dyes (SYTO‐9, SYBR Green I, SYBR Green II, SYBR Safe, and SYBR Gold) were used as both on‐column…
Expand
2014
2014
Detection of beta-globin gene mutations by syto-9 real-time PCR and high resolution melting
M. Khataminezhad
,
M. Mirinargesi
2014
Corpus ID: 37921835
Thalassemias, as the most important inherited blood disorders, are a wide group of inherited anemias that are caused by decreased…
Expand
Highly Cited
2007
Highly Cited
2007
Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae
P. C. Braga
,
M. Alfieri
,
M. Culici
,
M. Sasso
Mycoses (Berlin)
2007
Corpus ID: 38243761
As the capacity of Candida albicans to produce hyphae is considered an important virulence factor in the pathogenesis of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE